This article is more than 5 years old. Information may no longer be current.

FDA approves reverse shoulder system from FH Orthopedics

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

FH Orthopedics announced in a press release that the FDA has approved the company’s ARROW reverse shoulder replacement system.

According to a company press release, the ARROW system allows surgeons to perform both anatomical and reverse shoulder replacements using the same humeral stem and set of instruments. It allows surgeons to review their choice of shoulder prosthesis in the perioperative period. In cases of rotator cuff failure, for example, the stem can reportedly be left in place in order to turn the prosthesis into a reverse easily and less invasively. According to the release, the design of the reverse prosthesis avoids notching on the glenoid.

 “This shoulder prosthesis was developed according to the latest trends and expectations in shoulder arthroplasty. Worldwide, there has been high-demand for ARROW and we are thrilled that the complete system is now available in the US,” Eric Hermann, managing director of FH Orthopedics Inc, stated in the press release.